Outcome-targeted Therapy: Principle and Outcome Evaluation: Clinical Study and Phenotype-genotype Correlation

A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 230 participants.

Also called NCT06632834

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 230 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06632834
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Taiwan (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT06632834. Allocation not applicable; no masking; primary purpose treatment. Start 2020-08-15 (actual); primary completion 2025-01-19 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Outcome-targeted Therapy: Principle and Outcome Evaluation: Clinical Study and Phenotype-genotype Correlation
Condition
Dilated Cardiomyopathy
Intervention (Drug)
simvastatin therapy
Lead sponsor
National Taiwan University Hospital (class: other)

Record details

Record id
cardio:ct-nct06632834
Content hash
f53bf742131d691cea2e81479d30097abc2f85caae4d1660d8de47881b61f655